Citizenplus Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 16-12-2024
- Paid Up Capital ₹ 2.93 Cr
as on 16-12-2024
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 9.50 M
as on 16-12-2024
About Citizenplus Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.93 Cr.
The company currently has active open charges totaling ₹9.50 M.
Bala Turpuseema, Venkata Annamraju, and Sreehari Annamraju serve as directors at the Company.
- CIN/LLPIN
U24100TG2015PTC098583
- Company No.
098583
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Apr 2015
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Citizenplus Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sreehari Annamraju  | Managing Director | 19-Nov-2019 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venkata Annamraju | Director | 22-Apr-2015 | Current |
| Bala Turpuseema | Director | 12-Mar-2020 | Current |
Financial Performance of Citizenplus Pharmaceuticals.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Citizenplus Pharmaceuticals?
Unlock access to Citizenplus Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Constructora San Jose Gvk Projects And Technical Services Private LimitedActive 8 years 3 months
Bala Turpuseema is a mutual person
- Impegno Software Solutions Private LimitedActive 13 years 6 months
Bala Turpuseema is a mutual person
- Emri Hyderabad Emergency Response Services FoundationActive 1 year 9 months
Bala Turpuseema is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 06 Dec 2021 | ₹9.50 M | Open |
How Many Employees Work at Citizenplus Pharmaceuticals?
Unlock and access historical data on people associated with Citizenplus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Citizenplus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Citizenplus Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
